Stryker Corporation
SYK
Rank in Stocks
#200
Stryker Corporation functions as a prominent medical technology enterprise,... Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
Share Price
$294.17
Last synced: 2026-10-16
Market Cap
$112.84B
Change (1 day)
0.27%
Change (1 year)
-21.43%
Country
US
Trade Stryker Corporation (SYK)
Category
Healthcare
Operating Margin for Stryker Corporation (SYK)
Operating Margin as of October 2026 TTM: 22.03%
According to Stryker Corporation latest financial reports and stock price the company's current Operating Margin (TTM) is 22.03%. At the end of 2024 the company had an Operating Margin of 22.40%.
Operating Margin history for Stryker Corporation from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 22.03% | -1.65% |
| 2025 | 22.40% | 0.00% |
| 2024 | 22.40% | 7.28% |
| 2023 | 20.88% | 3.16% |
| 2022 | 20.24% | -8.00% |
| 2021 | 22.00% | 4.27% |
| 2020 | 21.10% | -7.29% |
| 2019 | 22.76% | -0.26% |
| 2018 | 22.82% | 2.61% |
| 2017 | 22.24% | -2.24% |
| 2016 | 22.75% | 0.49% |
| 2015 | 22.64% | -1.74% |
| 2014 | 23.04% | -0.99% |
| 2013 | 23.27% | 5.10% |
| 2012 | 22.14% | -6.70% |
| 2011 | 23.73% | -6.13% |
| 2010 | 25.28% | -1.40% |
| 2009 | 25.64% | 10.85% |
| 2008 | 23.13% | 4.57% |
| 2007 | 22.12% | 6.09% |
| 2006 | 20.85% | 5.14% |
| 2005 | 19.83% | 0.46% |
| 2004 | 19.74% | 5.17% |
| 2003 | 18.77% | 3.25% |
| 2002 | 18.18% | 0.22% |
| 2001 | 18.14% | 15.98% |
| 2000 | 15.64% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 17.03% | -99.23% |
US
|
|
| 17.86% | -99.19% |
IE
|
|
| 21.46% | -99.03% |
US
|
|
| 0.00% | - |
DE
|
|
| 28.09% | -98.72% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.